We are live on ! Find out more
VIA

Vident Investment Advisory Portfolio holdings

AUM $2.9B
1-Year Est. Return 24.67%
This Fund
S&P 500
This Quarter Est. Return
+6.06%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
AUM
$2.01B
AUM Growth
+$108M
Cap. Flow
+$43M
Cap. Flow %
2.13%
Top 10 Hldgs %
10.52%
Holding
958
New
123
Increased
340
Reduced
402
Closed
92

Sector Composition

Rank Sector Weight
1 Technology 28.91%
2 Healthcare 14.26%
3 Energy 10.63%
4 Industrials 9.91%
5 Consumer Discretionary 7.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STE icon
626
Steris
STE
$23.2B
$592K 0.03%
3,359
+86
+3% +$13.8K
UVV icon
627
Universal Corp
UVV
$1.15B
$591K 0.03%
14,115
-1,166
-8% -$49.9K
VAR
628
DELISTED
Varian Medical Systems, Inc.
VAR
$591K 0.03%
3,436
-98,429
-97% -$15.5M
AFL icon
629
Aflac
AFL
$60.7B
$588K 0.03%
16,181
-24,700
-60% -$899K
GE icon
630
GE Aerospace
GE
$382B
$587K 0.03%
18,917
+766
+4% +$24.9K
MSI icon
631
Motorola Solutions
MSI
$77.3B
$583K 0.03%
3,717
+313
+9% +$45.7K
COLD icon
632
Americold
COLD
$4.13B
$581K 0.03%
16,260
+8,691
+115% +$329K
FISV
633
Fiserv Inc
FISV
$28B
$575K 0.03%
5,587
+941
+20% +$93.7K
BKI
634
DELISTED
Black Knight, Inc. Common Stock
BKI
$574K 0.03%
6,589
-565
-8% -$44.5K
RACE icon
635
Ferrari
RACE
$72.1B
$572K 0.03%
3,106
-24
-0.8% -$4.46K
NLY icon
636
Annaly Capital Management
NLY
$17.4B
$568K 0.03%
19,942
-759
-4% -$22K
EIX icon
637
Edison International
EIX
$26.9B
$567K 0.03%
11,145
-5,870
-34% -$312K
BIO icon
638
Bio-Rad Laboratories Class A
BIO
$9.53B
$563K 0.03%
1,093
-83
-7% -$42K
VRTX icon
639
Vertex Pharmaceuticals
VRTX
$134B
$553K 0.03%
2,031
-1,191
-37% -$329K
IDXX icon
640
Idexx Laboratories
IDXX
$46.2B
$549K 0.03%
1,397
-345
-20% -$128K
SCHW
641
Charles Schwab
SCHW
$186B
$547K 0.03%
15,112
-37,560
-71% -$1.31M
TTEK icon
642
Tetra Tech
TTEK
$9.06B
$547K 0.03%
+28,640
New +$509K
BMRN icon
643
BioMarin Pharmaceuticals
BMRN
$13.5B
$545K 0.03%
7,160
+1,194
+20% +$121K
LII icon
644
Lennox International
LII
$14.9B
$544K 0.03%
1,997
-4,140
-67% -$1.11M
SNPS icon
645
Synopsys
SNPS
$78.7B
$539K 0.03%
+2,523
New +$514K
FCX icon
646
Freeport-McMoran
FCX
$96.4B
$538K 0.03%
+34,366
New +$496K
GS icon
647
Goldman Sachs
GS
$301B
$538K 0.03%
2,677
-3
-0.1% -$610
VFC icon
648
VF Corp
VFC
$5.81B
$538K 0.03%
7,655
+652
+9% +$42.1K
CPRT icon
649
Copart
CPRT
$27.2B
$537K 0.03%
20,416
-3,336
-14% -$80.8K
MASI
650
DELISTED
Masimo
MASI
$537K 0.03%
2,274
-231
-9% -$51.8K

Similar funds

Vident Investment Advisory's Q3 2020 Portfolio in Review

As of Q3 2020, Vident Investment Advisory held 958 positions worth $2.01B, up 5.6% from $1.91B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Vident Investment Advisory's Q3 2020 filing shows 123 new, 340 increased, 402 reduced and 92 closed positions. Its largest new stake was Zoom: 21,112 shares worth $9.93M. The largest sale was Varian Medical Systems, Inc., an estimated $15.5M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 27% a quarter earlier, followed by Healthcare and Energy.

  • Vident Investment Advisory's largest Q3 2020 buy was Zoom: 21,112 shares worth $9.93M.
  • Vident Investment Advisory added most to PIMCO 15+ Year US TIPS Index Exchange-Traded Fund in Q3 2020, an estimated $7.45M increase.
  • Vident Investment Advisory's biggest Q3 2020 reduction was Varian Medical Systems, Inc., cutting an estimated $15.5M.
  • Vident Investment Advisory fully exited Centene in Q3 2020, selling an estimated $3.67M.
  • Vident Investment Advisory's ten largest holdings make up 11% of its $2.01B portfolio in Q3 2020.
  • Vident Investment Advisory opened 123 new positions and closed 92 in Q3 2020.
  • Vident Investment Advisory's portfolio value rose 5.6% quarter-over-quarter to $2.01B.

Based on Vident Investment Advisory's 13F filing for Q3 2020, filed 12 Nov 2020.